Valuation: OrganiGram

Market Cap 184M 131M 114M 106M 97.66M 12.55B 187M 1.25B 492M 6.25B 494M 483M 20.95B P/E 2026 *
10.3x
P/E 2027 * 34.9x
Enterprise Value 184M 131M 114M 106M 97.66M 12.55B 187M 1.25B 492M 6.25B 494M 483M 20.95B EV / Sales 2026 *
0.55x
EV / Sales 2027 * 0.42x
Free-Float
69.74%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 15/01/2026
Director of Finance/CFO - 08/01/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 65 29/03/2018
Director/Board Member 56 17/12/2018
Director/Board Member 70 17/12/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.89%+9.83% - - 131M
-3.52%-0.52%+35.21%+204.86% 220M
-1.06%-2.11%+5.68%+86.00% 131M
+1.23%+5.00%-25.65%-12.48% 83.89M
-3.70%-.--%+1.30%-37.10% 79.16M
+9.34%+7.11%-38.28%-46.00% 56.18M
Average -0.27%+0.90%-4.35%+39.06% 114.04M
Weighted average by Cap. -1.55%+0.02%+7.53%+87.28%

Financials

2026 *2027 *
Net sales 336M 240M 208M 194M 178M 22.88B 341M 2.29B 897M 11.39B 900M 880M 38.19B 436M 311M 270M 252M 231M 29.7B 443M 2.97B 1.16B 14.79B 1.17B 1.14B 49.58B
Net income 18.08M 12.88M 11.2M 10.43M 9.57M 1.23B 18.35M 123M 48.23M 612M 48.39M 47.33M 2.05B 4M 2.85M 2.48M 2.31M 2.12M 272M 4.06M 27.19M 10.67M 136M 10.71M 10.47M 454M
Net Debt - -
Logo OrganiGram
Organigram Global Inc. is focused on producing cannabis for adult recreational consumers, as well as developing international business partnerships. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. It operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. It operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-